Discovery and development of biopeptides are time‐consuming, laborious, and dependent
on various factors. Data‐driven computational methods, especially machine learning (ML) …

In recent years, the occurrence of a wide variety of drug-resistant diseases has led to an
increase in interest in alternate therapies. Peptide-based drugs as an alternate therapy hold …

Over the past years, it has become evident that cancer initiation and progression depends
on several components of the tumor microenvironment, including inflammatory and immune …

The prolonged conventional approaches of drug screening and vaccine designing
prerequisite patience, vigorous effort, outrageous cost as well as additional manpower …

Tuberculosis is a global menace, caused by Mycobacterium tuberculosis, responsible for
millions of premature deaths every year. In the era of drug-resistant tuberculosis, peptide …

Saliva as a non-invasive diagnostic fluid has immense potential as a tool for early diagnosis
and prognosis of patients. The information about salivary biomarkers is broadly scattered …

Designing novel antimicrobial peptides is a hot area of research in the field of therapeutics
especially after the emergence of resistant strains against the conventional antibiotics. In the …

PRRDB 2.0 is an updated version of PRRDB that maintains comprehensive information
about pattern-recognition receptors (PRRs) and their ligands. The current version of the …

One of the most critical health challenges is sensitive early and ongoing disease detection
for prevention and personalized treatment management. Developing new sensitive …

Liver cancer is the fourth major lethal malignancy worldwide. To understand the
development and progression of liver cancer, biomedical research generated a tremendous …